Roche Holding AG’s cancer drug Tarceva nearly doubles the time patients with a distinct type of lung cancer live without their disease getting worse, a late-stage trial showed on Friday.

The…

Asian non-small cell lung cancer (NSCLC) patients survive longer than Caucasians no matter how many drugs are given in a first-line setting, and the effect was apparent…

Researchers with the International Agency for Research on Cancer (IARC) have found that people with lung cancer were significantly more likely to have several high-risk forms of…

Workers involved in mustard-gas production during the World War II era showed heightened odds of lung cancer at a relatively young age - with the excess risk fading in…

British scientists have found that counting the number of lung cancer cells circulating in a patient’s blood could help determine how aggressive the cancer is and predict the best treatment…

Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases…

An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of…

A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of…

The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its…

A new study has found that tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual’s risk of death from lung cancer. Published early online in Cancer, a…

More research is suggesting that heavy smokers may benefit from screening for lung cancer, to detect tumors in their earliest stages.

A new study finds that regular smokers who…

Dutch researchers have found that men who screen negative for lung cancer are a bit less likely to try to quit smoking than men whose scan is inconclusive and requires…

Eating five portions of fruit and vegetables per day is one of the means that experts most frequently recommend for preventing cancer. Now, the European EPIC study carried…

Proton beam therapy is safe and effective and may be superior to other conventional treatments for Stage I inoperable non-small cell lung cancer (NSCLC) patients, according to a…

For the first time, UK scientists have reported direct evidence that taking up smoking results in epigenetic changes associated with the development of cancer.

The results were reported at the…

A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a…

Race itself was not a prognostic factor of overall survival among black patients with lung cancer, according to data from a retrospective study presented at…

For the first time to date, research published in the October edition of the Journal of Thoracic Oncology (JTO)  sought to determine the use…

Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety…

A tiny molecule that spurs the progression of non-small-cell lung cancer could become a player in fighting the disease, say researchers at UT Southwestern Medical…

Cancer becomes life-threatening when tumor cells start leaving their primary site. They travel through the lymph and blood streams to other tissues where they grow into metastases. This transition to malignancy…

Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one…

Women who use estrogen-only hormone replacement therapy don’t appear to be at increased risk of dying from lung cancer.

That’s according to a new analysis of earlier data from…

Today, at the 52nd Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Philadelphia, a group of researchers from Stanford University will describe the latest developments…

Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib,…